当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3758521
已选条件
-
T81376PROTAC SMARCA2 degrader-2;化合物 PROTAC SMARCA2 degrader-2PROTAC SMARCA2 degrader-2
PROTAC SMARCA2 degrader-2, a selective and powerful degrader of SMARCA2/4, exhibits an IC50 of <0.1 μΜ in the HeLa HiBiT assay.this compound holds promise for research into cancers related to or deficient in SMARCA4 [1].
价 格:¥电议型 号:T81376产 地:中国大陆
-
T81374PROTAC TTK degrader-2;化合物 PROTAC TTK degrader-2PROTAC TTK degrader-2
PROTAC TTK Degrader-2 is a potent threonine tyrosine kinase (TTK) PROTAC degrader, achieving DC50 values of 3.1 nM in COLO-205 cells and 12.4 nM in HCT-116 cells. It demonstrates effective target degradation and anticancer activity in a COLO-205 human colorectal cancer cell xenograft mouse model [1].
价 格:¥电议型 号:T81374产 地:中国大陆
-
T81107SR-29065;化合物 SR-29065SR-29065
SR-29065 is a selective agonist of REV-ERBα, utilized in the research of autoimmune disorders [1].
价 格:¥电议型 号:T81107产 地:中国大陆
-
T80874VEGFR-2/c-Met-IN-1;化合物 VEGFR-2/c-Met-IN-1VEGFR-2/c-Met-IN-1
VEGFR-2/c-Met-IN-1 is a dual inhibitor targeting VEGFR-2 and c-Met with respective IC50 values of 138 nM and 74 nM, demonstrating antitumor activity [1].
价 格:¥电议型 号:T80874产 地:中国大陆
-
T80872VEGFR-2-IN-37;化合物 VEGFR-2-IN-37VEGFR-2-IN-37
VEGFR-2-IN-37 (compound 12), a VEGFR-2 inhibitor, exhibits an inhibition rate of approximately 56.9 μM at a concentration of 200 μM. It is also identified as a potential inhibitor of human umbilical vein endothelial cell (HUVEC) proliferation [1].
价 格:¥电议型 号:T80872产 地:中国大陆
-
T80647Androgen receptor degrader-2;化合物 Androgen receptor degrader-2Androgen receptor degrader-2
Androgen Receptor Degrader-2 (Compound 9) is a potent degrader of androgen receptors, with potential application in cancer research [1].
价 格:¥电议型 号:T80647产 地:中国大陆
-
T80535AMPR-22;化合物 AMPR-22AMPR-22
AMPR-22, an antimicrobial peptide, binds to bacterial membranes to induce permeabilization and has demonstrated efficacy in a murine sepsis model induced by multidrug-resistant (MDR) strains [1].
价 格:¥电议型 号:T80535产 地:中国大陆
-
T79904PROTAC CDK9/CycT1 Degrader-2;化合物 PROTAC CDK9/CycT1 Degrader-2PROTAC CDK9/CycT1 Degrader-2
PROTAC CDK9/CycT1 Degrader-2 inhibits CDK9 with an IC50 of 45 nM [1].
价 格:¥电议型 号:T79904产 地:中国大陆
-
T79860TIE-2/VEGFR-2 kinase-IN-5;TIE-2/VEGFR-2 kinase 抑制剂5TIE-2/VEGFR-2 kinase-IN-5
TIE-2/VEGFR-2 kinase-IN-5 is a potent TIE-2 and VEGFR-2 tyrosine kinase receptor inhibitor with anti-angiogenic activity and is commonly used in biomedical research related to angiogenesis.
价 格:¥电议型 号:T79860产 地:中国大陆
-
T79859TIE-2/VEGFR-2 kinase-IN-4;化合物 TIE-2/VEGFR-2 kinase-IN-4TIE-2/VEGFR-2 kinase-IN-4
TIE-2/VEGFR-2 kinase-IN-4, a benzimidazole derivative, serves as a potent inhibitor of the tyrosine kinase receptors TIE-2 and VEGFR-2, exhibiting inhibitory concentration (IC50) values of 5.2 nM and 5.1 nM, respectively. This compound is utilized in angiogenesis research [1].
价 格:¥电议型 号:T79859产 地:中国大陆
-
T79858TIE-2/VEGFR-2 kinase-IN-3;化合物 TIE-2/VEGFR-2 kinase-IN-3TIE-2/VEGFR-2 kinase-IN-3
TIE-2/VEGFR-2 kinase-IN-3, a benzimidazole derivative, serves as a potent inhibitor of the tyrosine kinase receptors TIE-2 and VEGFR-2, exhibiting IC50 values of 6.9 nM and 3.5 nM, respectively. This compound is useful for angiogenesis research [1].
价 格:¥电议型 号:T79858产 地:中国大陆
-
T79818PROTAC BRD4 Degrader-21;化合物 PROTAC BRD4 Degrader-21PROTAC BRD4 Degrader-21
PROTAC BRD4 Degrader-21 (Comp 74), a potent degrader of BRD4, has demonstrated substantial inhibition of tumor growth in mouse xenograft models, showing its potential for use in anticancer research [1].
价 格:¥电议型 号:T79818产 地:中国大陆
-
T79811DDR1/2 inhibitor-2;化合物 DDR1/2 inhibitor-2DDR1/2 inhibitor-2
DDR1/2 Inhibitor-2 (Example 31) serves as an inhibitor of DDR1/DDR2, exhibiting IC50 values below 100 nM. It is applicable in cancer and fibrotic disease research [1].
价 格:¥电议型 号:T79811产 地:中国大陆
-
T79742CARM1 degrader-2;化合物 CARM1 degrader-2CARM1 degrader-2
PROTAC CARM1 degrader-2 (compound 3e), with a DC50 value of 8.8 nM, is a VHL- and proteasome-dependent degrader of co-activator associated argininemethyltransferase (CARM1). It not only promotes the degradation of CARM1 but also prevents the methylation of its substrates, including poly(A)-binding protein PABP1 and BGR1-associated factor BAF155, which consequently inhibits breast cancer cell migration [1].
价 格:¥电议型 号:T79742产 地:中国大陆
-
T79591hCA/VEGFR-2-IN-4;化合物 hCA/VEGFR-2-IN-4hCA/VEGFR-2-IN-4
hCA/VEGFR-2-IN-4 (compound 15b), an indolinylbenzenesulfonamide, serves as a potential dual inhibitor targeting cancer-related human carbonic anhydrases hCA IX/XII and vascular endothelial growth factor receptor 2 (VEGFR-2). It exhibits an IC50 value of 0.811 ?M against VEGFR-2 and demonstrates high affinity for hCAs, with inhibition constants (Ki) of 3.8 nM for hCA XII, 6.2 nM for hCA IX, 19.8 nM for hCA II, and 35.5 nM for hCA I. Additionally, the compound shows antiproliferative effects on br
价 格:¥电议型 号:T79591产 地:中国大陆
-
T79588hCA/VEGFR-2-IN-3;化合物 hCA/VEGFR-2-IN-3hCA/VEGFR-2-IN-3
hCA/VEGFR-2-IN-3 (compound 8j) is an indolinonylbenzenesulfonamide with potential as a dual inhibitor of cancer-associated hCA IX/XII and VEGFR-2. This compound inhibits VEGFR-2 with an IC50 of 358 nM and exhibits high affinity for hCAs, evidenced by Ki values of 4.2 nM for hCA IX, 22.9 nM for hCA II, 25.1 nM for hCA I, and 28.0 nM for hCA XII. Additionally, hCA/VEGFR-2-IN-3 demonstrates antiproliferative activity specifically against breast cancer cells that overexpress VEGFR-2 [1].
价 格:¥电议型 号:T79588产 地:中国大陆
-
T79587hCA/VEGFR-2-IN-2;化合物 hCA/VEGFR-2-IN-2hCA/VEGFR-2-IN-2
Compound 8g (hCA/VEGFR-2-IN-2) is an indolinonylbenzenesulfonamide identified as a potential dual inhibitor targeting cancer-associated isozymes hCA IX/XII and the angiogenic receptor VEGFR-2. It demonstrates VEGFR-2 inhibition with an IC50 of 204 nM and high affinity for hCAs, exhibiting Kis of 3.6 nM for hCA IX, 16.1 nM for hCA II, 16.7 nM for hCA XII, and 75.3 nM for hCA I. Furthermore, compound 8g exhibits antiproliferative effects on breast cancer cells overexpressing VEGFR-2 [1].
价 格:¥电议型 号:T79587产 地:中国大陆
-
T79540hCA/VEGFR-2-IN-1;化合物 hCA/VEGFR-2-IN-1hCA/VEGFR-2-IN-1
hCA/VEGFR-2-IN-1 (compound 13a) is a potent dual inhibitor targeting both Carbonic Anhydrase (CA) IX/XII and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2). It exhibits Ki values of 4.7 nM for hCA XII and 8.3 nM for hCA IX, alongside an IC50 of 26.3 nM for VEGFR-2. This compound demonstrates anticancer activity [1].
价 格:¥电议型 号:T79540产 地:中国大陆
-
T79495VEGFR-2-IN-32;化合物 VEGFR-2-IN-32VEGFR-2-IN-32
VEGFR-2-IN-32 (Comp 3a) is an inhibitor of VEGFR-2, exhibiting an inhibitory concentration (IC 50) of 8.93 nM, and demonstrates cytotoxic activity towards PC-3 cells with an IC 50 of 1.22 μM, indicating its potential utility in anti-prostate cancer research [1].
价 格:¥电议型 号:T79495产 地:中国大陆
-
T79494VEGFR-2-IN-31;化合物 VEGFR-2-IN-31VEGFR-2-IN-31
VEGFR-2-IN-31 (compound 3i), a robust VEGFR-2 inhibitor (IC50=8.93 nM), serves as an anti-prostate cancer agent by arresting the cell cycle at the S-phase and inducing apoptosis.
价 格:¥电议型 号:T79494产 地:中国大陆